Search research articles
Contact Us
Filters
Showing results (21-30 of 32) with videos related to
Page
of 4
Sort By:
Current Diabetes Reports
|
September 1, 2018
Immune Mechanisms and Pathways Targeted in Type 1 Diabetes
Laura M Jacobsen, Brittney N Newby, Daniel J Perry, et al.
Biochemistry
|
April 21, 2016
Structural Effects of Two Camelid Nanobodies Directed to Distinct C-Terminal Epitopes on α-Synuclein
Farah El-Turk, Francisco N Newby, Erwin De Genst, et al.
Advanced Healthcare Materials
|
June 18, 2024
Branched-Tail Lipid Nanoparticles for Intravenous mRNA Delivery to Lung Immune, Endothelial, and Alveolar Cells in Mice
Daria M Strelkova Petersen, Ryan M Weiss, Khalid A Hajj, et al.
Research Square
|
June 22, 2026
PEG-associated efficacy loss in lipid nanoparticles persists across formulation modifications for mRNA delivery
Mariah L Arral, Namit Chaudhary, Katherine C Fein, et al.
Biophysical Journal
|
December 8, 2016
The Significance of the Location of Mutations for the Native-State Dynamics of Human Lysozyme
Minkoo Ahn, Christine L Hagan, Ana Bernardo-Gancedo, et al.
Diabetes
|
December 7, 2016
Interferon-γ Limits Diabetogenic CD8<sup>+</sup> T-Cell Effector Responses in Type 1 Diabetes
John P Driver, Jeremy J Racine, Cheng Ye, et al.
Nature Biomedical Engineering
|
October 3, 2024
Amine headgroups in ionizable lipids drive immune responses to lipid nanoparticles by binding to the receptors TLR4 and CD1d
Namit Chaudhary, Lisa N Kasiewicz, Alexandra N Newby, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 4, 2024
Lipid nanoparticle structure and delivery route during pregnancy dictate mRNA potency, immunogenicity, and maternal and fetal outcomes
Namit Chaudhary, Alexandra N Newby, Mariah L Arral, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 9, 2022
The strawberry-derived permeation enhancer pelargonidin enables oral protein delivery
Nicholas G Lamson, Katherine C Fein, John P Gleeson, et al.
Journal of Autoimmunity
|
February 10, 2020
Innate inflammation drives NK cell activation to impair Treg activity
Joseph W Dean, Leeana D Peters, Christopher A Fuhrman, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 32) with videos related to
Sort By:
Page
of 4
Current Diabetes Reports
|
September 1, 2018
Immune Mechanisms and Pathways Targeted in Type 1 Diabetes
Laura M Jacobsen, Brittney N Newby, Daniel J Perry, et al.
Biochemistry
|
April 21, 2016
Structural Effects of Two Camelid Nanobodies Directed to Distinct C-Terminal Epitopes on α-Synuclein
Farah El-Turk, Francisco N Newby, Erwin De Genst, et al.
Advanced Healthcare Materials
|
June 18, 2024
Branched-Tail Lipid Nanoparticles for Intravenous mRNA Delivery to Lung Immune, Endothelial, and Alveolar Cells in Mice
Daria M Strelkova Petersen, Ryan M Weiss, Khalid A Hajj, et al.
Research Square
|
June 22, 2026
PEG-associated efficacy loss in lipid nanoparticles persists across formulation modifications for mRNA delivery
Mariah L Arral, Namit Chaudhary, Katherine C Fein, et al.
Biophysical Journal
|
December 8, 2016
The Significance of the Location of Mutations for the Native-State Dynamics of Human Lysozyme
Minkoo Ahn, Christine L Hagan, Ana Bernardo-Gancedo, et al.
Diabetes
|
December 7, 2016
Interferon-γ Limits Diabetogenic CD8<sup>+</sup> T-Cell Effector Responses in Type 1 Diabetes
John P Driver, Jeremy J Racine, Cheng Ye, et al.
Nature Biomedical Engineering
|
October 3, 2024
Amine headgroups in ionizable lipids drive immune responses to lipid nanoparticles by binding to the receptors TLR4 and CD1d
Namit Chaudhary, Lisa N Kasiewicz, Alexandra N Newby, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 4, 2024
Lipid nanoparticle structure and delivery route during pregnancy dictate mRNA potency, immunogenicity, and maternal and fetal outcomes
Namit Chaudhary, Alexandra N Newby, Mariah L Arral, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 9, 2022
The strawberry-derived permeation enhancer pelargonidin enables oral protein delivery
Nicholas G Lamson, Katherine C Fein, John P Gleeson, et al.
Journal of Autoimmunity
|
February 10, 2020
Innate inflammation drives NK cell activation to impair Treg activity
Joseph W Dean, Leeana D Peters, Christopher A Fuhrman, et al.
Page
of 4